|
2025 Conference Publication Phase Ib/IIa dose escalation and expansion study of 212Pb-ADVC001 in metastatic castration-resistant prostate cancer (mCRPC): TheraPb-Phase I/II Trial in ProgressGoh, Jeffrey, Pattison, David, Ngai, Stanley, Katchel, Loren, Holmes, Ingrid, Baker, Sean, Biggs, Heather, Cuscaden, Claire, Campbell, Louise, Brady, Jasmine, Lindsay, Karen, Latter, Melissa, Griffiths, Matthew, O'Mahoney, Eoin, Dhiantravan, Nattakorn, Francis, Roslyn, Rose, Stephen, Soderholm, Amelia, Baronet, Meghan, Crumbaker, Megan, Kryza, Thomas, Shakti, Stelle, Naidoo, Sheruna, Puttick, Simon, Horsfall, Aimee, Barkhausen, Christoph, Kuan, Kevin, Santoro, Paola, Skingley, Lesley ... Hansen, Aaron (2025). Phase Ib/IIa dose escalation and expansion study of 212Pb-ADVC001 in metastatic castration-resistant prostate cancer (mCRPC): TheraPb-Phase I/II Trial in Progress. 2025 ANZUP Annual Scientific Meeting, Sydney, NSW Australia, 20-22 July 2025. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2025 Conference Publication Retrofitting a cyclotron solid target processing system for radiometal production at AIBN, cyclotron and radiochemistry capabilityStimson, Damion, Barkhausen, Christoph, Najdovski, Ljubco, Gulza, Arif, Dixon, Carl, Maillet, Donald and Thurecht, Kristofer (2025). Retrofitting a cyclotron solid target processing system for radiometal production at AIBN, cyclotron and radiochemistry capability. ANZSNM ASM 2025, Melbourne, VIC Australia, 23-25 May 2025. Hoboken, NJ, United States: Wiley. doi: 10.1111/imj.70120 |
|
2022 Conference Publication Establishing the radiopharmaceutical [11C]C-PiB as "ready-to-use" in humans at the CAIBarkhausen, C., Stimson, H. R., Najdovski, L. and Reutens, D. (2022). Establishing the radiopharmaceutical [11C]C-PiB as "ready-to-use" in humans at the CAI. Australian and New Zealand Society of Nuclear Medicine (ANZSNM) 52nd ASM, Brisbane, QLD, Australia, 13 – 15 May 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.15763 |
